| 摘要 |
<p>Described is use of 4-fluoro-N-indan-2-yl benzamide for the manufacture of a medicament for the treatment of stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction, stroke, thrombosis, peripheral artery occlusive disease, atherosclerosis, restenosis, endothel damage after PTCA, hypertension, essential hypertension, pulmonary hypertension, secondary hypertension, renovacsular hypertension, chronic glomerulonephritis, erectile dysfunction, ventricular arrhythmia, diabetes, nephropathy, retinopathy, angiogemesis, asthma bronchiale, chronic renal failure, cirrhosis of the liver or osteoporosis, or for the lowering of cardiovascular risk of postmenopausal women or after intake of contraceptive.</p> |
